GlassScriptPhysician profile
Myra C Liu
NPI 1912325994
$829.27
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507 · 2020: $184 · 2021: $75.35 · 2022: $21.38 · 2023: $23.93 · 2024: $17.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $41.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $41.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $223.10 | 2019-2021 | |
| Abbvie INC. | $98.77 | 2021-2023 | |
| Scilex Pharmaceuticals INC. | $63.02 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $57.78 | 2019 | |
| Amgen INC. | $57.21 | 2019-2020 | |
| Novo Nordisk INC | $54.32 | 2019-2020 | |
| Pfizer INC. | $40.03 | 2019 | |
| Antares Pharma, INC. | $31.93 | 2019 | |
| Sanofi Pasteur INC. | $30.88 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $28.29 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.48 | 2020 | |
| Genentech USA, INC. | $23.12 | 2020 | |
| Lilly USA, LLC | $20.99 | 2019 | |
| Abbott Laboratories | $17.71 | 2024 | Assurity |
| Neos Therapeutics, LP | $17.05 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15.82 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.64 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Myra Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.